Medicare Hearing Aid Coverage Act of 2017

Hearing Health Care Services. S. 2575/H.R. 2276, Audiology Patient Choice Act of 2018: Proposal to expand access to hearing health care services for Medicare beneficiaries. Hearing Aids. H.R. 3426, Medicare Hearing Aid Coverage Act: Proposal to provide Medicare coverage of hearing aids. Medicare Dental, Vision, and Hearing Coverage. H.R. 508, Seniors Have Eyes, Ears and Teeth Act and H.R. 3111, Medicare Dental, Vision, and Hearing Benefit Act of 2017: Proposals to expand Medicare coverage to include comprehensive coverage of dental, vision, and hearing care. Medicare Observation Status. S. 568/H.R. 1421, Improving Access to Medicare Coverage Act of 2017: Proposal to count days in the hospital in observation status toward meeting the three-day prior hospitalization requirement for skilled nursing facility care eligibility. Dementia and Alzheimers. S. 2076/H.R. 4256, Building Our Largest Dementia Infrastructure for Alzheimers Act (BOLD Act): Proposal to apply a public health approach to combat Alzheimers disease and related dementias. Alzheimers Disease. S. 2387/H.R. 4957, Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act of 2018: Proposal to aid Alzheimers disease suffers, their families and caregivers, including authorization of a cognitive impairment detection benefit in the Medicare annual wellness visit and initial preventive physical examination. Drug Price Negotiation. S. 2011/H.R. 4138, Medicare Drug Price Negotiation Act: Proposals to lower prescription drug prices in the Medicare Part D program, including allowing Medicare to negotiate directly with prescription drug manufacturers and requiring drug manufacturers to rebate to the federal government for drugs covered under Medicare Part D for low-income Medicare beneficiaries. Generic Drug Introduction. S. 974/H.R. 2212, CREATES Act: Proposal to speed the introduction of generic competition by curbing brand drug maker abuses of safety procedures as a means to limit generic manufacturer access to the drug samples needed to obtain Food and Drug Administration approval. Opioid Treatment. H.R. 6, SUPPORT for Patients and Communities Act: Section 2005 proposals related to Medicare coverage of certain services furnished by opioid treatment programs. Medicare Beneficiary Equitable Relief. (No bill): Efforts to extend and make permanent the Centers for Medicare and Medicaid Services policy for equitable relief for select individuals currently or previously enrolled in Marketplace plans who delayed Medicare enrollment during their Initial Enrollment Period or during a qualifying Special Enrollment Period. Medicare Physician Payment. (No bill): Proposal to collapse the current five levels of payments for office visits (Evaluation and Management) into two levels. Medicare and Medicaid Protection. S. 3330, Medicare and Medicaid Protection Act: Proposed changes to budget reconciliation legislation affecting Medicare and Medicaid program protections. Medicaid Protection. (No bill): Proposals requiring Medicaid recipients to work and ending homecare workers rights to make deductions from their pay for health care and union dues. Medicare Prescription Drug Costs. (May be attached to several legislative vehicles.) Proposals to reduce amount drug manufacturers must contribute to closing the donut hole. Medicare Prescription Drug Costs. S. 2553, Know the Lowest Price Act of 2018: Proposal to prohibit Medicare Advantage plans from putting clauses in contracts with pharmacists prohibiting them from disclosing to beneficiaries when a drug is less expensive if the beneficiary doesnt use his or her insurance. Medicare Part B Drug Costs. H.R. 5150, Protecting Medicare from Excessive Price Increases Act of 2018: Proposal to reduce Medicare Part B drug costs by requiring Medicare to rebate to the government the amount by which a drug price increase exceeds an inflation limit. Medicare Open Enrollment. (No bill). Efforts to ensure the Centers for Medicare and Medicaid Services conducts open enrollment in a way that is unbiased toward the traditional program.

Client expense: $210,000 · Firm income: Not reported

Government targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE, Social Security Administration (SSA), Treasury, Dept of

Hearing Health Care Services. S. 2575/H.R. 2276, Audiology Patient Choice Act of 2018: Proposal to expand access to hearing health care services for Medicare beneficiaries. Hearing Aids. H.R. 3426, Medicare Hearing Aid Coverage Act: Proposal to provide Medicare coverage of hearing aids. Medicare Dental, Vision, and Hearing Coverage. H.R. 508, Seniors Have Eyes, Ears and Teeth Act and H.R. 3111, Medicare Dental, Vision, and Hearing Benefit Act of 2017: Proposals to expand Medicare coverage to include comprehensive coverage of dental, vision, and hearing care. Medicare Observation Status. S. 568/H.R. 1421, Improving Access to Medicare Coverage Act of 2017: Proposal to count days in the hospital in observation status toward meeting the three-day prior hospitalization requirement for skilled nursing facility care eligibility. Opioid Treatment. S. 2704/H.R. 4097, Medicare Beneficiary Opioid Addiction Treatment Act: Proposal to provide for coverage of methadone under Medicare Part B. Dementia and Alzheimers. S. 2076/H.R. 4256, Building Our Largest Dementia Infrastructure for Alzheimers Act (BOLD Act): Proposal to apply a public health approach to combat Alzheimers disease and related dementias; Alzheimers Disease. S. 2387/H.R. 4957, Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act of 2018: Proposal to aid Alzheimers disease suffers, their families and caregivers, including authorization of a cognitive impairment detection benefit in the Medicare annual wellness visit and initial preventive physical examination. Drug Price Negotiation. S. 2011/H.R. 4138, Medicare Drug Price Negotiation Act: Proposals to lower prescription drug prices in the Medicare Part D program, including allowing Medicare to negotiate directly with prescription drug manufacturers and requiring drug manufacturers to rebate to the federal government for drugs covered under Medicare Part D for low-income Medicare beneficiaries. Generic Drug Introduction. S. 974/H.R. 2212, CREATES Act: Proposal to speed the introduction of generic competition by curbing brand drug maker abuses of safety procedures as a means to limit generic manufacturer access to the drug samples needed to obtain Food and Drug Administration approval. Prescription Drug costs. S. 2553/H.R. 6144, the Know the Lowest Price Act: Proposal to prohibit health plans and pharmacy benefits managers from utilizing contract gag clauses prohibiting pharmacists from disclosing to consumers when it costs less to pay out-of-pocket for a prescription than it would using their insurance coverage. Medicare Part B Drug Costs . H.R. 5150, Protecting Medicare from Excessive Price Increases Act of 2018: Proposal to reduce Medicare Part B drug costs by requiring Medicare to rebate to the government the amount by which a drug price increase exceeds an inflation limit. Medicare Beneficiary Education. (No bill): Efforts to improve the Centers for Medicare and Medicaid outreach and education during open enrollment.

Client expense: $260,000 · Firm income: Not reported

Government targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Office of Management & Budget (OMB), President of the U.S., SENATE, Social Security Administration (SSA), Treasury, Dept of, Vice President of the U.S.

2018 Medicare Open Enrollment (No bill). The Center for Medicare and Medicaid Services Administrations public outreach and education around the 2018 Medicare open enrollment. Medicare Dental, Vision, and Hearing Coverage. H.R. 508, Seniors Have Eyes, Ears and Teeth Act and H.R. 3111, Medicare Dental, Vision, and Hearing Benefit Act of 2017: Proposals to expand Medicare coverage to include comprehensive coverage of dental, vision, and hearing care. Medicare Hearing Coverage. H.R. 3426, Medicare Hearing Aid Coverage Act: Proposal to provide Medicare coverage of hearing aids. Medicare Observation Status. S. 568, H.R. 1421, Improving Access to Medicare Coverage Act of 2017: Proposal to count days in the hospital in observation status toward meeting the three-day prior hospitalization requirement for skilled nursing facility care eligibility. Beneficiary Enrollment Notification and Eligibility . S. 1909, H. R. 2575, Beneficiary Enrollment Notification and Eligibility Simplification Act: Proposals to improve Medicare Part B enrollment and to align Part B, Medicare Advantage and Part D rules. Opioid Treatment for Seniors. H.R. 5085, Expanding Access to Evidence-Based Opioid Treatment for Seniors Act of 2018: Proposal to require Medicare to recognize substance abuse treatment facilities as independent providers. Dementia and Alzheimers. S. 2076, Building Our Largest Dementia Infrastructure for Alzheimers Act (BOLD Act), Proposal for applying a public health approach to combat Alzheimers disease and related dementias. Medicare Privatization (No bill). Proposals to transform traditional Medicare into a private insurance carrier program. Medicare Eligibility Age (No bill). Proposal to raise the eligibility age for Medicare from 65 to 67. National Survey of Older Americans Act Participants (No bill). Proposal to have the Administration for Community Living reinstate a demographic question on gender identity. Money Follows the Person (No bill). Proposal to reauthorize a demonstration that provides funding and support for states to transition individuals living in institutional care settings into settings that are more integrated with their communities. Alex M. Azars Nomination to head the Department of Health and Human Services (No bill). Questions pertaining to Mr. Azars positions on the Affordable Care Act, Medicaid block granting, and his background as a pharmaceutical executive. Medicare Part B Prices. H.R. 5150, Protecting Medicare from Excessive Price Increases Act of 2018: Proposal to require drug manufacturers to rebate to the Secretary of Health and Human Services the amount by which a drug exceeds past prices above inflation. Drug Price Negotiation. S. 2011, H.R. 4138, Medicare Drug Price Negotiation Act: Proposals to lower prescription drug prices in the Medicare Part D program, including allowing Medicare to negotiate directly with prescription drug manufacturers. Requires drug manufacturers to provide a rebate to the federal government for drugs covered under Medicare Part D for low-income Medicare beneficiaries. Generic Drug Market Anticompetitive Behavior. S.974, H.R.2212, CREATES Act of 2017: Proposal to curb abuses by brand drug makers that prevent or delay generic drug manufacturers from getting sufficient samples of the brand drugs needed to obtain FDA approval, keeping generics off the market and driving up drug costs.

Client expense: $250,000 · Firm income: Not reported

Government targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Office of Management & Budget (OMB), President of the U.S., SENATE, Social Security Administration (SSA), Treasury, Dept of, Vice President of the U.S.